Scientific Background | Peptide E, sometimes catalogued as BAM-3200 for its approximate mass, is the longest of the proenkephalin A fragments offered in this series. The supplied sequence shares the Met-enkephalin opening common to the BAM peptides and carries a substantially longer C-terminal region, reflected in a molecular weight above 3100 against roughly 2335 for BAM-18P and 1425 for BAM-12P. Peptide E is notable within proenkephalin biology because it contains both a Met-enkephalin sequence at its N-terminus and a Leu-enkephalin sequence at its C-terminus, so a single precursor fragment carries two distinct opioid recognition motifs. Proteolytic processing of peptide E generates shorter BAM peptides, which places it upstream of the other members of this series rather than alongside them, and gives it particular relevance to studies of how the processing pathway determines which mature peptides a tissue produces. For experimental use, the length has practical consequences worth anticipating. Longer peptides of this type are more susceptible to proteolysis in tissue preparations, so recovery and stability should be checked rather than assumed, and apparent activity may partly reflect generation of shorter fragments during the assay. Where a stable, defined opioid agonist is the goal, a shorter member of the series is the more straightforward choice; peptide E is the reagent when the processing pathway itself is the subject. |
